InnoPharma has announced that it has received approval from the Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Decitabine for Injection, a generic version of Eisai's Dacogen.
The origin of the latest Ebola outbreak has been traced to a single transmission from animal to human that spread during the course of a funeral.
Vital Connect announced that the Food and Drug Administration (FDA) has granted clearance for its HealthPatch MD biosensor for 24-hour patient monitoring in their homes.
Pfizer and Protalix BioTherapeutics announced that the Food and Drug Administration (FDA) has approved Elelyso (taliglucerase alfa) for injection for pediatric patients.
Takeda announced their completion and data submission of a 10-year epidemiology study to regulatory authorities, including the United States Food and Drug Administration (FDA).